(+)-Myrrhanol C made


Spanish chemists have completed the stereospecific total synthesis of (+)-myrrhanol C.

(+)-Myrrhanol C is a natural triterpene isolated from mastic gum (the resin of Pistacia lentiscus), a substance well known for its medicinal properties as well as use in various cuisines. The compound itself was used to embalm corpses in ancient Egypt. More recently, it has been recognised as a promising anti-prostate cancer lead. However, before a molecule can be used to develop drugs, a successful synthesis must be developed.

Pistacia lentiscus

Mastic gum (from Pistacia lentiscus, pictured) has been used for many applications, from treating snakebites to tooth whiteners. © Science Photo Library

Alejandro Barrero and his group at the University of Granada have done just that. Their synthesis starts with (–)-sclareol, a bicyclic diterpene alcohol isolated from clary sage (Salvia sclarea). It then proceeds through a key C–H oxidation step, which is achieved with cytochrome P450 enzyme catalysis by incubating a reaction intermediate with the fungus Mucor plumbeus.

By cultivating clary sage, Barrero can sustainably produce (–)-sclareol, meaning (+)-myrrhanol C can be made on a large scale that is also environmentally friendly.

However, the use of natural products and processes in the synthesis also gives another important benefit to the synthetic strategy. ‘Apart from using a natural chiral synthon as starting material, the only process generating a new chiral centre is the microbial hydroxylation,’ explains Barrero. This means the researchers could carefully control the stereochemistry of the synthetic product, which could be very important for clinical applications. ‘The selectivity [for the (+) isomer] of our synthesis is total,’ he concludes.

Bob Hill, a natural products expert at the University of Glasgow, welcomes the synthesis of (+)-myrrhanol C even though he is not enthused by the chemistry. ‘They seem to have produced a reasonably good synthesis (using established methodology) to a potentially useful compound,’ he says.

Barrero says that the next step is to investigate synthetic analogues and their antitumour activity with a view to drug discovery.


Related Content

The sultan of synthesis

11 April 2014 Feature

news image

Phil Baran is spurring organic chemists to rethink how they make complex compounds, as Mark Peplow discovers

Stepping toward ideality

6 July 2012 Premium contentFeature

news image

James Mitchell Crow wonders what would make the perfect organic synthesis

Most Read

Better batteries with pure lithium anodes

28 July 2014 Research

news image

Protective carbon nanosphere coating overcomes lithium problems, pointing the way to improved capacity

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point